Hospitals in One of the Fastest Growing States in the Nation Bolstering Medical Equipment Inventory With Support From US Med-Equip

Hospitals in one of the fastest-growing states in the nation are bolstering inventory of life-saving equipment to provide an increasing number of patients with the best care possible. US Med-Equip opened a new office in Las Vegas to support healthcare providers in Nevada and across the West with faster-than-ever access to patient-ready equipment.

One of the nation’s fastest-growing private companies featured in Inc. magazine’s Inc. 5000 list, US Med-Equip (USME) specializes in the rental, sales, service and asset management of movable medical equipment—diagnostic and clinical devices ranging from infusion pumps and patient monitors to ventilators, baby incubators and more.

“As Nevada hospitals experience surges in the number of patients in their care, healthcare staff are focused on continuing to do what they do best: help patients heal,” USME President Ed Gay said. “Our Las Vegas branch will at a moment’s notice do whatever it takes to help healthcare providers in the Silver State get the critical equipment they need.”

Hospitals in Nevada and across the country are streamlining processes and turning to smarter options from trusted partners like USME to ensure they have the equipment and biomedical expertise when they need it to provide patients the best care possible. The company is expanding rapidly to meet growing demand while investing heavily in its equipment fleet and the technology and services to support it.

US Med-Equip serves thousands of hospitals from more than 40 locations across the country with more on the way. The new westernmost branch is part of USME’s $30 million investment in the Western U.S. with new offices also opening this quarter in Denver and Salt Lake City.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version